Weekend roundup: Campbell in the soup | New cancer gene therapy | Exposing bad investment advice – MarketWatch

Posted: September 2, 2017 at 5:47 am

MarketWatch rounded up 10 of its most interesting topics over the past week.

Campbell Soup Co. CPB, -1.73% had a rough quarter, but the company is facing a dire long-term problem.

Novartis AG NVS, -0.57% received FDA approval for the first cancer gene therapy available in the U.S. Emma Court explained how important this is for young people suffering from a type of acute lymphoblastic leukemia (ALL), and she interviewed Janney analyst Paul Knight, who made recommendations for investors on how to play a potential decade-long growth cycle for gene therapy.

Here are charts that will help you sift through a boatload of absurdity spouted every day by self-styled stock-market gurus.

Nissan Motor Co. 7201, +0.27% is about to launch a redesigned Leaf electric car. The company has a big advantage over Tesla Inc. TSLA, -0.14% because of its huge manufacturing scale, but one big question is the new Leafs battery range, as Claudia Assis reports.

The startling increase in value for bitcoin rivals that of other types of assets that have bubbled and burst. Andrew Left believes the Bitcoin Investment Trust GBTC, -20.40% is a very dangerous investment.

The damage from Hurricane Harvey to the Houston area has been devastating. The coming flurry of activity as the damage is repaired might cause a rise in U.S. GDP, but Caroline Baum calls claims of real economic benefits predictable nonsense.

Amazon.com Inc. AMZN, -0.24% was called the weakest major U.S. retailer this week by Moodys Investors Service. But T. Rowe Price Media and Telecommunications Fund PRMTX, -0.38% is a big believer. The fund, which had more than quadrupled the S&P 500s return over the past 15 years, had more than 10% of its assets in Amazons shares as of July 31.

If you are retired, you might think it will be very difficult to get a mortgage loan because of low income. But there are many financing options available for those without a steady monthly income, according to Darrow Kirkpatrick.

Jeff Reeves weighs the pros and cons of scooping up shares of Apple Inc. AAPL, +0.03% right now.

If you get excited by Labor Day sales, you might be missing out on bigger savings later.

Want more from MarketWatch? Check out our Personal Finance Daily or other newsletters, and get the latest news, personal finance and investing advice.

Here is the original post:
Weekend roundup: Campbell in the soup | New cancer gene therapy | Exposing bad investment advice - MarketWatch

Related Posts